blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1241176

EP1241176 - Purine derivatives for the treatment of ischemia [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.02.2007
Database last updated on 21.09.2024
Most recent event   Tooltip22.05.2009Change - representativepublished on 24.06.2009  [2009/26]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[N/P]
Former [2002/38]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Inventor(s)01 / Deninno, Michael Paul, Pfizer Global Research
and Development, Eastern Point Road
Groton, Connecticut 06340 / US
02 / Masamune, Hiroko, Pfizer Global Research
and Development, Eastern Point Road
Groton, Connecticut 06340 / US
 [2002/38]
Representative(s)Hayles, James Richard, et al
Pfizer
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
[N/P]
Former [2009/26]Hayles, James Richard, et al
Pfizer Limited Patents Department Ramsgate Road Sandwich
Kent CT13 9NJ / GB
Former [2002/38]Hayles, James Richard, et al
UK Patent Department, Pfizer Limited, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date02251174.520.02.2002
[2002/38]
Priority number, dateUS20010276411P16.03.2001         Original published format: US 276411 P
[2002/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1241176
Date:18.09.2002
Language:EN
[2002/38]
Search report(s)(Supplementary) European search report - dispatched on:EP13.06.2002
ClassificationIPC:C07H19/16, C07D473/34, C07D471/04, A61K31/7076, A61P9/10, // (C07D471/04, 235:00, 221:00)
[2002/38]
CPC:
C07D473/00 (EP,US); A61P39/00 (EP); A61P41/00 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07D471/04 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/38]
TitleGerman:Purinderivate zur Behandlung von Ischämie[2002/38]
English:Purine derivatives for the treatment of ischemia[2002/38]
French:Dérivés de purine pour le traitement de l'ischémie[2002/38]
Examination procedure02.03.2002Examination requested  [2002/38]
29.08.2006Application deemed to be withdrawn, date of legal effect  [2007/10]
12.10.2006Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2007/10]
Fees paidRenewal fee
19.12.2003Renewal fee patent year 03
28.02.2005Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
28.02.200605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DA]US5688774  (JACOBSON KENNETH A [US], et al) [DA] 1-11 * claim - *;
 [A]WO9808855  (CV THERAPEUTICS INC [US], et al) [A] 1-11 * claim - *;
 [A]WO0023447  (AVENTIS PHARM PROD INC [US], et al) [A] 1-11 * claim - *;
 [PA]WO0123399  (PFIZER PROD INC [US], et al) [PA] 1-11* claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.